… angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial

…, R Hernandez, A Bethencourt… - Journal of the American …, 2006 - jacc.org
… Finally, the rate of target vessel revascularization and the event-free survival at one year
A complete one-year clinical follow-up was obtained in all 150 patients (100%). Table 3…

… score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial

…, MA Morel, GA Van Es, P Buszman, A Linke… - Journal of the American …, 2010 - jacc.org
… LEADERS trial (patients after surgical revascularization were … patients with major cardiac
eventfree survival in the highest … the SYNTAX trial and the ARTS II (Arterial Revascularization

Twelve Months Clinical Outcome of Drug‐Eluting Stents Implantation or Coronary Artery Bypass Surgery for the Treatment of Diabetic Patients with Multivessel …

Y Qiao, C Ma, S Nie, X Liu, J Kang, Q Lv… - … Indexed and Peer …, 2009 - Wiley Online Library
… In the ARTS I15 complete revascularization was more frequently achieved … The effect of
completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll …

[HTML][HTML] Complete Coronary Revascularization and Outcomes in Patients Who Underwent Coronary Artery Bypass Grafting: Insights from The REGROUP Trial

L Belyayev, EM Stock, B Hattler, FG Bakaeen… - The American Journal of …, 2024 - Elsevier
1-year assessment of the ARTS trial by van den Brand et al showed no difference between
CR and IR when limited to just the first year in … of the STICH trial cohort indicated no impact of …

Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results

…, E Bonizzoni, G Stankovic, F Airoldi, A Chieffo… - Journal of the American …, 2004 - jacc.org
… by the Kaplan-Meier estimates of event-free survival among patients who reached 250-day …
effect of completeness of revascularization on event-free survival at one year in the ARTS trial

Association of incomplete revascularization with long-term survival after off-pump coronary artery bypass grafting

G Yi, YN Youn, HC Joo, S Hong, KJ Yoo - journal of surgical research, 2013 - Elsevier
… Thus, complete revascularization (CR) is considered one of the … In the BARI trial, 1507
patients were evaluated with 7 years of … failed to show better 1-year event-free survival for the CR …

[PDF][PDF] … surgery versus stenting for the treatment of multivessel disease: A meta-analysis with individual patient data from the ARTS, SoS, ERACI II and MASS II trials

…, RH Stables, WW O'Neill, A Rodriguez… - … revascularization in … - repub.eur.nl
… and conduits per patient, completeness of revascularisation, use of platelet glycoprotein IIb…
one year follow-up included death, myocardial infarction (MI), stroke, repeat revascularisation

Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial

…, R Senior, A Chiribiri, G Carr-White, A Pavlidis… - JAMA …, 2023 - jamanetwork.com
… benefit of revascularization above medical … viability is correlated with event-free survival
or left ventricular recovery and which viability characteristics are associated with the effect

The Society of Thoracic Surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting

GS Aldea, FG Bakaeen, J Pal, S Fremes… - The Annals of thoracic …, 2016 - Elsevier
complete revascularization and improved graft patency. … SITA grafting (Arterial
Revascularization Trial) is under way and … significant difference in event-free survival between the …

A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight-year …

SN Hoffman, JA TenBrook, MP Wolf, JB Wong… - Journal of the American …, 2003 - jacc.org
… We found a 1.9% absolute survival advantage favoring CABG over PTCA for all trials at five
effect of completeness of revascularization on event-free survival at one year in the ARTS trial